Advertisement Orthofix signs new agreement with MBA Group - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Orthofix signs new agreement with MBA Group

Orthofix International, a medical device company, has signed an agreement with the MBA Group, a distributor of orthopedic devices, to expand the distribution of the company's spine implant and biologic devices in the UK.

The new five-year agreement with MBA is effective as of May 1, 2009.

Alan Milinazzo, president and CEO of Orthofix, said: “MBA has been a key partner during Orthofix’s growth over the last 20 years and, after successfully expanding our relationship last year to include the distribution of our spine implant products in Spain and Portugal, we are excited to further expand our spine distribution agreement with them into the important UK market.”